Chris Mancill | Senior Vice President, Head, US Market Access
AstraZeneca

Chris Mancill, Senior Vice President, Head, US Market Access, AstraZeneca

At Bristol Myers Squibb, Chris leads the company's Global Market Access, Pricing, and Value Demonstration (MAx) function, which is focused on defining and articulating the value of the BMS portfolio to payers and other access stakeholders around the globe and developing innovative solutions to help ensure appropriate patient access. Immediately before moving into his current role, he led the MAx function at BMS in the United States. Chris has 30 years of experience in access, pricing, government affairs, and reimbursement at the global and market levels and has held leadership roles at the global and market levels at small to large biopharmaceutical companies, including Amgen, MERCK, and MorphoSys. In addition to his responsibilities at BMS, Chris is a Member of the Board of Directors at the National Pharmaceutical Council and the ACCESS Forum.

Appearances:



World EPA Congress - Day 1 @ 09:40

Industry commitments and collaborations to health system goals

last published: 10/Feb/25 15:45 GMT

back to speakers

Get Involved 
 

Sponsorship & Exhibition Sales


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

Conference Production


George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com